Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines

Alphaherpesviruses, including herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), and varicella-zoster virus (VZV), infect a diverse array of hosts, spanning both humans and animals. Alphaherpesviruses have developed a well-adapted relationship with their hosts through long-ter...

Full description

Saved in:
Bibliographic Details
Main Authors: Shinuo Cao, Mo Zhou, Shengwei Ji, Dongxue Ma, Shanyuan Zhu
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/13/9/779
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850260050754404352
author Shinuo Cao
Mo Zhou
Shengwei Ji
Dongxue Ma
Shanyuan Zhu
author_facet Shinuo Cao
Mo Zhou
Shengwei Ji
Dongxue Ma
Shanyuan Zhu
author_sort Shinuo Cao
collection DOAJ
description Alphaherpesviruses, including herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), and varicella-zoster virus (VZV), infect a diverse array of hosts, spanning both humans and animals. Alphaherpesviruses have developed a well-adapted relationship with their hosts through long-term evolution. Some alphaherpesviruses exhibit a typical neurotropic characteristic, which has garnered widespread attention and in-depth research. Virus latency involves the retention of viral genomes without producing infectious viruses. However, under stress, this can be reversed, resulting in lytic infection. Such reactivation events can lead to recurrent infections, manifesting as diseases like herpes labialis, genital herpes, and herpes zoster. Reactivation is a complex process influenced by both viral and host factors, and identifying how latency and reactivation work is vital to developing new antiviral therapies. Recent research highlights a complex interaction among the virus, neurons, and the immune system in regulating alphaherpesvirus latency and reactivation. Neurotropic alphaherpesviruses can breach host barriers to infect neurons, proliferate extensively within their cell bodies, and establish latent infections or spread further. Whether infecting neurons or spreading further, the virus undergoes transmission along axons or dendrites, making this process an indispensable part of the viral life cycle and a critical factor influencing the virus’s invasion of the nervous system. Research on the transmission process of neurotropic alphaherpesviruses within neurons can not only deepen our understanding of the virus but can also facilitate the targeted development of corresponding vaccines. This review concentrates on the relationship between the transmission, latency, and activation of alphaherpesviruses within neurons, summarizes recent advancements in the field, and discusses how these findings can inform the design of live virus vaccines for alphaherpesviruses.
format Article
id doaj-art-829df4a4e81e47ae8cd09fec6f23624f
institution OA Journals
issn 2076-0817
language English
publishDate 2024-09-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj-art-829df4a4e81e47ae8cd09fec6f23624f2025-08-20T01:55:45ZengMDPI AGPathogens2076-08172024-09-0113977910.3390/pathogens13090779Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector VaccinesShinuo Cao0Mo Zhou1Shengwei Ji2Dongxue Ma3Shanyuan Zhu4Jiangsu Key Laboratory for High-Tech Research and Development of Veterinary Biopharmaceuticals, Jiangsu Agri-Animal Husbandry Vocational College, Taizhou 225306, ChinaJiangsu Key Laboratory for High-Tech Research and Development of Veterinary Biopharmaceuticals, Jiangsu Agri-Animal Husbandry Vocational College, Taizhou 225306, ChinaDepartment of Veterinary Medicine, Agriculture College of Yanbian University, Yanji 133000, ChinaDepartment of Veterinary Medicine, Agriculture College of Yanbian University, Yanji 133000, ChinaJiangsu Key Laboratory for High-Tech Research and Development of Veterinary Biopharmaceuticals, Jiangsu Agri-Animal Husbandry Vocational College, Taizhou 225306, ChinaAlphaherpesviruses, including herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), and varicella-zoster virus (VZV), infect a diverse array of hosts, spanning both humans and animals. Alphaherpesviruses have developed a well-adapted relationship with their hosts through long-term evolution. Some alphaherpesviruses exhibit a typical neurotropic characteristic, which has garnered widespread attention and in-depth research. Virus latency involves the retention of viral genomes without producing infectious viruses. However, under stress, this can be reversed, resulting in lytic infection. Such reactivation events can lead to recurrent infections, manifesting as diseases like herpes labialis, genital herpes, and herpes zoster. Reactivation is a complex process influenced by both viral and host factors, and identifying how latency and reactivation work is vital to developing new antiviral therapies. Recent research highlights a complex interaction among the virus, neurons, and the immune system in regulating alphaherpesvirus latency and reactivation. Neurotropic alphaherpesviruses can breach host barriers to infect neurons, proliferate extensively within their cell bodies, and establish latent infections or spread further. Whether infecting neurons or spreading further, the virus undergoes transmission along axons or dendrites, making this process an indispensable part of the viral life cycle and a critical factor influencing the virus’s invasion of the nervous system. Research on the transmission process of neurotropic alphaherpesviruses within neurons can not only deepen our understanding of the virus but can also facilitate the targeted development of corresponding vaccines. This review concentrates on the relationship between the transmission, latency, and activation of alphaherpesviruses within neurons, summarizes recent advancements in the field, and discusses how these findings can inform the design of live virus vaccines for alphaherpesviruses.https://www.mdpi.com/2076-0817/13/9/779alphaherpesvirusesneuronslatencyreactivationlive vector vaccine
spellingShingle Shinuo Cao
Mo Zhou
Shengwei Ji
Dongxue Ma
Shanyuan Zhu
Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines
Pathogens
alphaherpesviruses
neurons
latency
reactivation
live vector vaccine
title Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines
title_full Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines
title_fullStr Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines
title_full_unstemmed Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines
title_short Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines
title_sort recent advances in the study of alphaherpesvirus latency and reactivation novel guidance for the design of herpesvirus live vector vaccines
topic alphaherpesviruses
neurons
latency
reactivation
live vector vaccine
url https://www.mdpi.com/2076-0817/13/9/779
work_keys_str_mv AT shinuocao recentadvancesinthestudyofalphaherpesviruslatencyandreactivationnovelguidanceforthedesignofherpesviruslivevectorvaccines
AT mozhou recentadvancesinthestudyofalphaherpesviruslatencyandreactivationnovelguidanceforthedesignofherpesviruslivevectorvaccines
AT shengweiji recentadvancesinthestudyofalphaherpesviruslatencyandreactivationnovelguidanceforthedesignofherpesviruslivevectorvaccines
AT dongxuema recentadvancesinthestudyofalphaherpesviruslatencyandreactivationnovelguidanceforthedesignofherpesviruslivevectorvaccines
AT shanyuanzhu recentadvancesinthestudyofalphaherpesviruslatencyandreactivationnovelguidanceforthedesignofherpesviruslivevectorvaccines